290 related articles for article (PubMed ID: 10534607)
1. The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain.
Gear RW; Miaskowski C; Gordon NC; Paul SM; Heller PH; Levine JD
Pain; 1999 Nov; 83(2):339-45. PubMed ID: 10534607
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptics antagonize nalbuphine antianalgesia.
Gear RW; Lee JS; Miaskowski C; Gordon NC; Paul SM; Levine JD
J Pain; 2006 Mar; 7(3):187-91. PubMed ID: 16516824
[TBL] [Abstract][Full Text] [Related]
3. Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans.
Gear RW; Gordon NC; Miaskowski C; Paul SM; Heller PH; Levine JD
Neurosci Lett; 2003 Nov; 351(1):5-8. PubMed ID: 14550900
[TBL] [Abstract][Full Text] [Related]
4. Sexual dimorphism in very low dose nalbuphine postoperative analgesia.
Gear RW; Gordon NC; Miaskowski C; Paul SM; Heller PH; Levine JD
Neurosci Lett; 2003 Mar; 339(1):1-4. PubMed ID: 12618286
[TBL] [Abstract][Full Text] [Related]
5. A subanalgesic dose of morphine eliminates nalbuphine anti-analgesia in postoperative pain.
Gear RW; Gordon NC; Hossaini-Zadeh M; Lee JS; Miaskowski C; Paul SM; Levine JD
J Pain; 2008 Apr; 9(4):337-41. PubMed ID: 18201935
[TBL] [Abstract][Full Text] [Related]
6. Kappa-opioids produce significantly greater analgesia in women than in men.
Gear RW; Miaskowski C; Gordon NC; Paul SM; Heller PH; Levine JD
Nat Med; 1996 Nov; 2(11):1248-50. PubMed ID: 8898754
[TBL] [Abstract][Full Text] [Related]
7. Experimental pain models reveal no sex differences in pentazocine analgesia in humans.
Fillingim RB; Ness TJ; Glover TL; Campbell CM; Price DD; Staud R
Anesthesiology; 2004 May; 100(5):1263-70. PubMed ID: 15114226
[TBL] [Abstract][Full Text] [Related]
8. NOP receptor mediates anti-analgesia induced by agonist-antagonist opioids.
Gear RW; Bogen O; Ferrari LF; Green PG; Levine JD
Neuroscience; 2014 Jan; 257():139-48. PubMed ID: 24188792
[TBL] [Abstract][Full Text] [Related]
9. Absence of nalbuphine anti-analgesia in the rat.
Khasar SG; Gear RW; Levine JD
Neurosci Lett; 2003 Jul; 345(3):165-8. PubMed ID: 12842282
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Full ยต-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists - Preclinical and Clinical Evidence.
van Niel JC; Schneider J; Tzschentke TM
Drug Res (Stuttg); 2016 Nov; 66(11):562-570. PubMed ID: 27504867
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
[TBL] [Abstract][Full Text] [Related]
12. Onset and offset of intrathecal morphine versus nalbuphine for postoperative pain relief after total hip replacement.
Fournier R; Van Gessel E; Macksay M; Gamulin Z
Acta Anaesthesiol Scand; 2000 Sep; 44(8):940-5. PubMed ID: 10981570
[TBL] [Abstract][Full Text] [Related]
13. Nalbuphine.
Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG
Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929
[TBL] [Abstract][Full Text] [Related]
14. Opioid agonist-antagonist drugs in acute and chronic pain states.
Hoskin PJ; Hanks GW
Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
[TBL] [Abstract][Full Text] [Related]
15. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC
Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816
[TBL] [Abstract][Full Text] [Related]
16. Gender difference in analgesic response to the kappa-opioid pentazocine.
Gear RW; Gordon NC; Heller PH; Paul S; Miaskowski C; Levine JD
Neurosci Lett; 1996 Mar; 205(3):207-9. PubMed ID: 8852594
[TBL] [Abstract][Full Text] [Related]
17. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
Craft RM; McNiel DM
Pharmacol Biochem Behav; 2003 Apr; 75(1):235-45. PubMed ID: 12759132
[TBL] [Abstract][Full Text] [Related]
18. A mechanistic model for the sex-specific response to nalbuphine and naloxone in postoperative pain.
Kshirsagar S; Gear R; Levine J; Verotta D
J Pharmacokinet Pharmacodyn; 2008 Feb; 35(1):69-83. PubMed ID: 17943420
[TBL] [Abstract][Full Text] [Related]
19. Combination of opioid agonist and agonist-antagonist: patient-controlled analgesia requirement and adverse events among different-ratio morphine and nalbuphine admixtures for postoperative pain.
Yeh YC; Lin TF; Lin FS; Wang YP; Lin CJ; Sun WZ
Br J Anaesth; 2008 Oct; 101(4):542-8. PubMed ID: 18640992
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal morphine for postoperative analgesia following repair of frontal encephaloceles in children: comparison with intermittent, on-demand dosing of nalbuphine.
Tobias JD; Mateo C; Ferrer MJ; Jimenez DF; Barone CM; Reyes de Castro L
J Clin Anesth; 1997 Jun; 9(4):280-4. PubMed ID: 9195349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
